The US Trade Commission’s Ruling on InnoScience’s GaN Products and Its Market Implications

On July 7, 2026, the United States International Trade Commission (US ITC) finalized a decision that bars InnoScience (Suzhou) Technology Holding Co., Ltd. from importing and selling its gallium nitride (GaN) power semiconductor products in the United States. The ruling follows a 60‑day review period that began on May 7, 2026, and was upheld by the U.S. President. Infineon Technologies AG, a German semiconductor leader, cited a patent infringement in the GaN technology domain that InnoScience allegedly violated.

The US ITC’s Final Determination, issued on May 7, 2026, concluded that InnoScience’s GaN chips infringed an Infineon patent. When the review period expired, the Commission’s decision became definitive. Infineon’s senior executive, Johannes Schoiswohl, emphasized the company’s commitment to protecting its intellectual property and maintaining fair competition. The ruling effectively prohibits InnoScience from:

  1. Importing any infringing GaN products into the U.S. market.
  2. Offering these products for purchase by U.S. customers.

This action aligns with the broader U.S. strategy of enforcing patent rights in the semiconductor sector, which is increasingly central to emerging technologies such as renewable energy, data centers, and electric vehicles.

Impact on InnoScience’s Business

InnoScience, founded in 2015 and headquartered in Suzhou, China, has positioned itself as a key player in GaN wafer, discrete chip, integrated circuit, and module manufacturing. Its product portfolio serves consumer electronics, renewable energy, industrial automation, automotive electronics, and data‑center applications worldwide. The company’s market capitalization, as of the latest reporting, stands at approximately 55.5 billion HKD.

The US ban represents a significant market loss. The United States is one of the largest consumers of GaN power devices, especially for high‑performance power supplies and electric‑vehicle charging systems. While InnoScience maintains a strong presence in China and other international markets, exclusion from the U.S. will:

  • Reduce revenue streams derived from U.S. distributors and OEMs.
  • Increase pressure on existing supply chains to secure alternative components.
  • Potentially erode investor confidence, reflected in the share price movement (HKD 56.8 on July 5, 2026, compared with a 52‑week high of HKD 106.1).

Competitive Dynamics and Market Reactions

Infineon’s own GaN manufacturing capability is underpinned by a 300‑millimeter wafer line, positioning it as a leader in scaling GaN technology. The ruling thus consolidates Infineon’s competitive advantage in markets where patent enforcement is critical.

For competitors, the decision underscores the importance of robust intellectual‑property strategies. Companies that invest in their own GaN R&D, secure patents, and establish independent manufacturing lines may mitigate exposure to similar disputes. Conversely, firms reliant on third‑party suppliers must reassess contractual relationships to avoid infringement risks.

Broader Implications for the Semiconductor Industry

The case illustrates the increasing intersection of technology innovation, intellectual property law, and international trade policy. As GaN devices become integral to energy‑efficient power systems—offering higher switching frequencies, lower losses, and superior thermal performance compared to silicon—patents in this arena are becoming valuable assets. The ruling may prompt:

  • Greater collaboration between semiconductor firms and legal counsel to navigate cross‑border IP challenges.
  • Accelerated development of domestic GaN manufacturing capabilities in countries facing export restrictions.
  • A reevaluation of supply‑chain diversification strategies to reduce geopolitical exposure.

Conclusion

InnoScience’s inability to access the U.S. market due to the US ITC’s enforcement of Infineon’s patent rights marks a pivotal moment for the company and the GaN sector. While the loss is significant, it also serves as a catalyst for InnoScience to strengthen its IP portfolio, expand alternative market footholds, and potentially invest in its own manufacturing capacity. For the broader industry, the decision reinforces the critical role of intellectual property protection in sustaining innovation and competitive balance in a rapidly evolving technology landscape.